Jeryl Lynn
Jeryl Lynn are strains of mumps virus used in the Mumpsvax mumps vaccine made by Merck. The strains are named after Jeryl Lynn Hilleman. In 1963, Jeryl's father, Maurice Hilleman, was leading efforts to produce a mumps vaccine for Merck. He cultured the mumps virus from her throat, and in 1967 a vaccine was produced which is now widely used.[1]
The Jeryl Lynn strains used in the manufacture of Mumpsvax later turned out to contain two distinguishable viral substrains, JL1 and JL2.[2] Further research showed that the JL1 strain was preferentially selected by propagation in Vero and chick embryo fibroblast (CEF) cell cultures. The JL2 strain was preferentially selected by passage in embryonated chicken eggs.[3]
In the US, the Jeryl Lynn strain-based vaccines supplanted the previous, killed virus, vaccine in 1978.[1]
See also
[edit]References
[edit]- ^ a b World Health Organization (March 1998). "The Mumps Vaccine". Immunization, Vaccines and Biologicals. Archived from the original on 2006-04-23. Retrieved 2006-05-24.
- ^ Amexis G, Oeth P, Abel K, Ivshina A, Pelloquin F, Cantor C, Braun A, Chumakov K, Brau A (2001). "Quantitative mutant analysis of viral quasispecies by chip-based matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry". Proc Natl Acad Sci USA. 98 (21): 12097–102. Bibcode:2001PNAS...9812097A. doi:10.1073/pnas.211423298. PMC 59774. PMID 11593021.
- ^ Amexis G, Rubin S, Chizhikov V, Pelloquin F, Carbone K, Chumakov K (2002). "Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control". Virology. 300 (2): 171–79. doi:10.1006/viro.2002.1499. PMID 12350348.